MedTrace Logo

Value of Robotic Rectopexy for the Treatment of Complex Pelvic Floor Dysfunction

NCT01346436 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-05-05

No results posted yet for this study

Summary

The purpose of this randomized double blind controlled study is to assess the value of robotics for the treatment of complex pelvic floor dysfunction. The main aim is to compare perioperative and functional outcomes to the laparoscopic approach.

Conditions

  • Rectal Prolapse
  • Pelvic Organ Prolapse

Interventions

PROCEDURE

Minimally invasive rectopexy

Use of a minimally invasive approach (robotic or laparoscopy) to perform a rectopexy

Sponsors & Collaborators

  • Nicolas C. Buchs

    lead OTHER

Principal Investigators

  • Nicolas C Buchs, MD · University Hospital, Geneva

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01346436 on ClinicalTrials.gov